# Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD

Study · id `cardio:ct-nct03150667` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03150667](<https://clinicaltrials.gov/study/NCT03150667>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03150667

Browse, organ or system: Heart; Kidneys  
Browse, condition area: Coronary and vascular disease; Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 220 participants.

## Technical summary

Registry record NCT03150667. Randomized; no masking; primary purpose prevention. Start 2017-04-10 (actual); primary completion 2019-04-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 220 participants (planned count; ClinicalTrials.gov record NCT03150667, source copy `cardio:ctgov-nct03150667-2018-05-25`, retrieved 2026-10-26)
- Started: 2017-04-10 (actual) (ClinicalTrials.gov record NCT03150667, source copy `cardio:ctgov-nct03150667-2018-05-25`, retrieved 2026-10-26)
- Primary completion: 2019-04-30 (anticipated) (ClinicalTrials.gov record NCT03150667, source copy `cardio:ctgov-nct03150667-2018-05-25`, retrieved 2026-10-26)
- Completion: 2020-04-30 (anticipated) (ClinicalTrials.gov record NCT03150667, source copy `cardio:ctgov-nct03150667-2018-05-25`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03150667, source copy `cardio:ctgov-nct03150667-2018-05-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03150667-2018-05-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD
- Acronym: CPRS-CKD
- Condition: Chronic Kidney Diseases
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Ticagrelor
- Intervention (Drug): Clopidogrel
- Lead sponsor: North Texas Veterans Healthcare System
- Lead sponsor class: FED

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)
- Registry lists this organization as the lead sponsor: North Texas Veterans Healthcare System (`cardio:org-north-texas-veterans-healthcare-system`)

## Provenance

Content hash: 82fd6aedf45eef0a79f0f77dcfd90cf21c062ca5d254a6fff4bb083cfbf3048e
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
